Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia

Glucagon and glucagon-like peptide (GLP)-1 are the primary products of proglucagon processing from the pancreas and gut, respectively. Giving dual agonists with glucagon and GLP-1 activity to diabetic, obese mice causes enhanced weight loss and improves glucose tolerance by reduction of food intake...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tan, Tricia M., Field, Benjamin C.T., McCullough, Katherine A., Troke, Rachel C., Chambers, Edward S., Salem, Victoria, Gonzalez Maffe, Juan, Baynes, Kevin C.R., De Silva, Akila, Viardot, Alexander, Alsafi, Ali, Frost, Gary S., Ghatei, Mohammad A., Bloom, Stephen R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3609580/
https://ncbi.nlm.nih.gov/pubmed/23248172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db12-0797
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados